期刊
JOURNAL OF CONTROLLED RELEASE
卷 303, 期 -, 页码 130-150出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2019.04.025
关键词
Vaccine adjuvant-delivery system; Mucosal vaccination; Pathogen-associated molecular pattern; Antigen cross-presentation; Immunoresponse; Cellular immunity
资金
- National Natural Science Foundation of China [81703449]
- Natural Science Foundation of Anhui Province [1708085QH196]
- Department of Education of Anhui Province [KJ2016SD28, gxfxZD2016045]
- Department of Human Resource & Social Security of Anhui Province [2018H173]
Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to their merits of high loading capacity, targeting delivery, reliable protection of agents, good biocompatibility, versatile structure modification and adjustable characteristics, such as size, surface charge, membrane flexibility and the agent loading mode. In particular, in recent years, through modification with immunopotentiators and targeting molecules, and in combination with innovative immunization devices, liposomes are rapidly developed as a multifunctional vaccine adjuvant-delivery system (VADS) that has a high capability in inducing desired immunoresponses, as they can target immune cells and even cellular organelles, engender lysosome escape, and promote Ag cross-presentation, thus enormously enhancing vaccination efficacy. Moreover, after decades of development, several products developed on liposome VADS have already been authorized for clinical immunization and are showing great advantages over conventional vaccines. This article describes in depth some critical issues relevant to the development of liposomes as a VADS, including principles underlying immunization, physicochemical properties of liposomes as the immunity-influencing factors, functional material modification to enhance immunostimulatory functions, the state-of-the-art liposome VADSs, as well as the marketed vaccines based on a liposome VADS. Therefore, this article provides a comprehensive reference to the development of novel liposome vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据